Health Condition 1: L818- Other specified disorders of pigmentation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Participants aged 18years and above . 2.Induviduals seeking chemical peeling for skin rejuvenation or specific dermatological conditions like acne , dyspigmentation for participation in the study . 3.Participants with Fitzpatrick skin types I TO IV . 4. Ability to provide informed consent
Exclusion criteria
Exclusion criteria: 1.Patients with a history of allergic reactions to chemical peeling agents . 2. Patients who are pregnant or breastfeeding 3.Induviduals with active skin infections ,wounds , or lesion at the treatment site . 4.Patients with a history of keloid formation or hypertrophic scarring. 5. Patients with uncontrolled medical conditions that may interfere with the safety or efficacy of chemical peeling procedures . 6.Induviduals currently using oral or topical retinoids ,corticosteroids or ,other medications that may affect skin sensitivity or response to chemical peeling
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Uniformity of Chemical Peeling , which is the consistency of chemical peel application and evenness of skin exfoliation and Assessment Tool includes Clinical photography and evaluation by blinded dermatologists or assessors. 2.Skin Improvement in skin texture, tone, or reduction in specific conditions (e.g., acne scars, pigmentation) and Assessment Tool includes Visual Analog Scale (VAS) or validated scoring systems like the Fitzpatrick Wrinkle Scale or Melasma Area and Severity Index (MASI). Timepoint: 1.Baseline (pre-peel). 2.Follow-ups at 2 weeks, 4 weeks, and 8 weeks post-procedure. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Safety and Adverse Events 2.Patient Satisfaction 3.Ease of Applicator Use 4.Cost-EffectivenessTimepoint: 1.Immediately post-application. 2.At follow-ups (Day 7, Day 14, and 3 weeks) and end of the study . | — |
Countries
India
Contacts
Saveetha Medical College and Hospital, SIMATS, Chennai .